Breaking News Instant updates and real-time market news.

CERN

Cerner

$60.63

0.65 (1.08%)

18:15
05/17/18
05/17
18:15
05/17/18
18:15

Cerner rises over 8% afterhours following VA contract announcement

  • 18

    May

  • 12

    Jun

CERN Cerner
$60.63

0.65 (1.08%)

05/04/18
RHCO
05/04/18
NO CHANGE
Target $58
RHCO
Hold
Cerner price target lowered to $58 from $68 at SunTrust
SunTrust analyst Sandy Draper lowered his price target on Cerner to $58, saying the downside from his previously expressed concerns about a difficult market, high multiple, and optimistic consensus came "quicker than expected". The analyst states that the company should consider share repurchases in order to generate double-digit EPS growth given the "difficult macro environment".
05/03/18
SBSH
05/03/18
NO CHANGE
Target $71
SBSH
Buy
Cerner pullback an 'enhanced' buying opportunity, says Citi
Citi analyst Stephanie Demko views the post-earnings pullback in shares of Cerner as an "enhanced" buying opportunity. Following the quarter, the analyst has greater confidence in her view that Cerner is well positioned to win the Veterans Affairs contract in the second half of 2018. She keeps a Buy rating on the stock with a $71 price target.
05/03/18
KEYB
05/03/18
NO CHANGE
Target $65
KEYB
Overweight
Cerner price target lowered to $65 from $76 at KeyBanc
KeyBanc analyst Donald Hooker lowered his price target for Cerner to $65 from $76 in light of a slowdown in client purchasing decisions driven by a maturing HCIT marketplace, health system consolidation, and an uncertain healthcare policy environment, compounded by uncertainty around the timing of the company's large $10B pending contract with the U.S. Department of Veterans Affairs. The analyst reiterates an Overweight rating on the shares.
05/03/18
PIPR
05/03/18
NO CHANGE
Target $64
PIPR
Overweight
Cerner earnings selloff a buying opportunity, says Piper Jaffray
Piper Jaffray analyst Sean Wieland lowered his price target for Cerner to $64 from $70 but keeps an Overweight rating on the name. The $65M revenue miss in Q1 and $162M guide-down were primarily due to the delayed Veterans Affairs contract signing, Wieland tells investors in a post-earnings research note titled "Lookin' for Growth in All the Wrong Places." Cerner removed a portion of the VA from guidance, which will likely pressure shares, the analyst adds. He recommends buying the shares on the post-earnings weakness. Quarterly bookings growth of 12% remains above industry norms and the VA deal will happen, eventually, Wieland contends. Further, he believes Cerner is well positioned to "expand the platform to reduce friction costs among the multiple stakeholders in the healthcare value chain."

TODAY'S FREE FLY STORIES

TSM

TSMC

$39.24

0.77 (2.00%)

12:40
02/20/19
02/20
12:40
02/20/19
12:40
Options
Taiwan Semi sees opening put buying »

Taiwan Semi sees opening…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HMHC

Houghton Mifflin

$8.94

0.52 (6.18%)

12:37
02/20/19
02/20
12:37
02/20/19
12:37
Hot Stocks
Houghton Mifflin Harcourt launches HMH Audio in-house audio production studio »

Houghton Mifflin Harcourt…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Feb

  • 28

    Feb

EA

Electronic Arts

$99.25

-3.73 (-3.62%)

, ATVI

Activision Blizzard

$43.82

-0.66 (-1.48%)

12:35
02/20/19
02/20
12:35
02/20/19
12:35
On The Fly
Game On: An exclusive talk with Beamdog CEO Trent Oster »

'NEVERWINTER NIGHTS'…

EA

Electronic Arts

$99.25

-3.73 (-3.62%)

ATVI

Activision Blizzard

$43.82

-0.66 (-1.48%)

TTWO

Take-Two

$89.77

-3.52 (-3.77%)

NTDOY

Nintendo

$0.00

(0.00%)

MSFT

Microsoft

$106.99

-0.77 (-0.71%)

SNE

Sony

$46.86

0.65 (1.41%)

TCEHY

Tencent

$0.00

(0.00%)

UBSFY

Ubisoft

$0.00

(0.00%)

CCOEY

Capcom

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Feb

  • 25

    Feb

  • 03

    Mar

  • 04

    Mar

  • 04

    Mar

  • 06

    Mar

  • 07

    Mar

  • 12

    Mar

  • 13

    Mar

  • 18

    Mar

12:35
02/20/19
02/20
12:35
02/20/19
12:35
General news
FOMC minutes preview: the minutes will be scrutinized »

FOMC minutes preview: the…

OSPN

OneSpan

$20.13

3.355 (20.00%)

12:33
02/20/19
02/20
12:33
02/20/19
12:33
Downgrade
OneSpan rating change  »

Imperial downgrades…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Feb

  • 25

    Feb

  • 11

    Mar

  • 12

    Mar

  • 28

    Mar

OSPN

OneSpan

$20.21

3.435 (20.48%)

12:28
02/20/19
02/20
12:28
02/20/19
12:28
Downgrade
OneSpan rating change  »

OneSpan downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Feb

  • 25

    Feb

  • 11

    Mar

  • 12

    Mar

  • 28

    Mar

KMI

Kinder Morgan

$19.20

0.05 (0.26%)

12:27
02/20/19
02/20
12:27
02/20/19
12:27
Hot Stocks
Kinder Morgan Chairman Richard Kinder buys over 19K shares of company stock »

Kinder Morgan Chairman…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    May

NYT

New York Times

$32.02

0.06 (0.19%)

12:25
02/20/19
02/20
12:25
02/20/19
12:25
Hot Stocks
New York Times publisher responds to Trump's 'enemy of the people' tweet »

After President Trump…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Feb

  • 25

    Feb

RTTR

Ritter Pharmaceuticals

$0.66

-0.0104 (-1.55%)

12:25
02/20/19
02/20
12:25
02/20/19
12:25
Conference/Events
Ritter Pharmaceuticals to host conference call »

Expert call with Dr Chey,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Feb

ZNGA

Zynga

$5.09

-0.01 (-0.20%)

12:20
02/20/19
02/20
12:20
02/20/19
12:20
Options
Defensive option play in Zynga as shares ease off 52-week highs »

Defensive option play in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Feb

  • 25

    Feb

  • 11

    Mar

  • 11

    Mar

HSY

Hershey

$109.97

0.275 (0.25%)

12:19
02/20/19
02/20
12:19
02/20/19
12:19
Earnings
Hershey issues long-term adjusted EPS growth target of 6%-8% »

Hershey in conference…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Feb

  • 03

    Mar

MCS

Marcus

$40.59

1 (2.53%)

12:18
02/20/19
02/20
12:18
02/20/19
12:18
Hot Stocks
Marcus raises quarterly dividend 6.7% to 16c per share »

Directors of The Marcus…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

  • 21

    Feb

  • 02

    Apr

  • 02

    Apr

  • 06

    Jun

HSY

Hershey

$109.95

0.255 (0.23%)

12:18
02/20/19
02/20
12:18
02/20/19
12:18
Hot Stocks
Hershey would consider debt to EBITDA ratio over 2.0 times for acquisition »

Hershey in conference…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Feb

  • 03

    Mar

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

12:17
02/20/19
02/20
12:17
02/20/19
12:17
Technical Analysis
NASDAQ market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

$0.00

(0.00%)

12:16
02/20/19
02/20
12:16
02/20/19
12:16
Technical Analysis
NYSE market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

12:15
02/20/19
02/20
12:15
02/20/19
12:15
General news
FX Action: USD-JPY »

FX Action: USD-JPY has…

CVS

CVS Health

$64.92

-5 (-7.15%)

, TSLA

Tesla

$302.25

-3.31 (-1.08%)

12:11
02/20/19
02/20
12:11
02/20/19
12:11
On The Fly
Fly Intel: Wall Street's top stories at midday »

Stocks opened little…

CVS

CVS Health

$64.92

-5 (-7.15%)

TSLA

Tesla

$302.25

-3.31 (-1.08%)

BMY

Bristol-Myers

$51.21

-0.14 (-0.27%)

CELG

Celgene

$91.25

0.54 (0.60%)

KNDI

Kandi Technologies

$8.45

2.52 (42.50%)

GRMN

Garmin

$82.11

11.145 (15.71%)

NVTA

Invitae

$18.55

2.06 (12.49%)

OMI

Owens & Minor

$6.48

-1.46 (-18.39%)

WIX

Wix.com

$110.43

-15.275 (-12.15%)

CXO

Concho Resources

$114.44

-6.51 (-5.38%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Feb

  • 20

    Feb

  • 20

    Feb

  • 20

    Feb

  • 20

    Feb

  • 20

    Feb

  • 21

    Feb

  • 22

    Feb

  • 22

    Feb

  • 25

    Feb

  • 25

    Feb

  • 25

    Feb

  • 27

    Feb

  • 27

    Feb

  • 28

    Feb

  • 12

    Mar

  • 18

    Mar

  • 18

    Mar

  • 19

    Mar

  • 18

    May

  • 20

    May

  • 22

    May

  • 28

    May

HSY

Hershey

$110.01

0.315 (0.29%)

12:09
02/20/19
02/20
12:09
02/20/19
12:09
Hot Stocks
Hershey reaffirms 2019 guidance at CAGNY Conference »

Hershey said that in a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Feb

  • 03

    Mar

KNX

Knight-Swift

$34.96

0.73 (2.13%)

12:05
02/20/19
02/20
12:05
02/20/19
12:05
Options
Knight Transportation call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Feb

  • 21

    Feb

12:05
02/20/19
02/20
12:05
02/20/19
12:05
General news
U.S. corporate bond update: the calendar remains active. »

U.S. corporate bond…

DNLI

Denali Therapeutics

$21.44

-0.16 (-0.74%)

12:03
02/20/19
02/20
12:03
02/20/19
12:03
Hot Stocks
Denali granted orphan status for mucopolysaccharidosis treatment »

The FDA granted Denali…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RDY

Dr. Reddy's

$35.97

-0.45 (-1.24%)

12:03
02/20/19
02/20
12:03
02/20/19
12:03
Hot Stocks
Dr. Reddy's announces re-launch of buprenorphine, naloxone sublingual film »

Dr. Reddy's…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Mar

HSY

Hershey

$109.86

0.165 (0.15%)

12:01
02/20/19
02/20
12:01
02/20/19
12:01
Earnings
Hershey backs FY19 adjusted EPS growth view of 5%-7%, consensus $5.64 »

Backs FY19 net sales…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Feb

  • 03

    Mar

QTT

Qutoutiao

$12.66

0.25 (2.01%)

12:01
02/20/19
02/20
12:01
02/20/19
12:01
Downgrade
Qutoutiao rating change  »

Qutoutiao downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Mar

BHC

Bausch Health

$23.23

-1.94 (-7.71%)

12:00
02/20/19
02/20
12:00
02/20/19
12:00
Hot Stocks
Bausch Health falls -7.7% »

Bausch Health is down…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Feb

  • 20

    Feb

  • 25

    Feb

  • 25

    Feb

  • 25

    Feb

  • 12

    Mar

  • 12

    Mar

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.